Skip to main content
Erschienen in: Rheumatology International 5/2012

01.05.2012 | Letter to the Editor

Lack of anti-insulin, anti-GAD, and anti-IA2 autoantibodies in primary antiphospholipid syndrome

verfasst von: Jozélio Freire de Carvalho, Maria Teresa Correia Caleiro

Erschienen in: Rheumatology International | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …
Literatur
1.
Zurück zum Zitat Michels AW, Nakayama M (2010) The anti-insulin trimolecular complex in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 17:329–334PubMedCrossRef Michels AW, Nakayama M (2010) The anti-insulin trimolecular complex in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 17:329–334PubMedCrossRef
2.
Zurück zum Zitat Lidar M, Braf A, Givol N, Langevitz P, Pauzner R, Many A, Livneh A (2001) Antiinsulin antibodies and the natural autoimmune response in systemic lupus erythematosus. Lupus 10:81–86PubMedCrossRef Lidar M, Braf A, Givol N, Langevitz P, Pauzner R, Many A, Livneh A (2001) Antiinsulin antibodies and the natural autoimmune response in systemic lupus erythematosus. Lupus 10:81–86PubMedCrossRef
3.
Zurück zum Zitat Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311PubMedCrossRef Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311PubMedCrossRef
4.
Zurück zum Zitat Klinman DM, Steinberg AD (1987) Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 165:1755–1760PubMedCrossRef Klinman DM, Steinberg AD (1987) Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 165:1755–1760PubMedCrossRef
5.
Zurück zum Zitat Nell LJ, Hulbert C, Arem R et al (1989) Factors affecting the insulin autoantibody ELISA. Autoimmunity 2:299–309PubMedCrossRef Nell LJ, Hulbert C, Arem R et al (1989) Factors affecting the insulin autoantibody ELISA. Autoimmunity 2:299–309PubMedCrossRef
6.
Zurück zum Zitat Blackshear PJ, Rother HE, Kriauciunas K, Kahn CR (1983) Reactive hypoglycemia and insulin autoantibodies in drug induced lupus erythematosus. Ann Intern Med 99:182–184PubMed Blackshear PJ, Rother HE, Kriauciunas K, Kahn CR (1983) Reactive hypoglycemia and insulin autoantibodies in drug induced lupus erythematosus. Ann Intern Med 99:182–184PubMed
7.
Zurück zum Zitat Di Mario U, Perfetti R, Anastasi E et al (1990) Autoantibodies to insulin do appear in non-diabetic patients with autoimmune disorders: comparison with autoimmunoglobulin antibodies and other autoimmune phenomena. Acta Endocrinol (Copenh) 122:303–308 Di Mario U, Perfetti R, Anastasi E et al (1990) Autoantibodies to insulin do appear in non-diabetic patients with autoimmune disorders: comparison with autoimmunoglobulin antibodies and other autoimmune phenomena. Acta Endocrinol (Copenh) 122:303–308
8.
Zurück zum Zitat Nakamura M, Burastero SE, Ueki Y, Larrick JW, Notkins AL, Casali P (1988) Probing the normal and autoimmune B cell repertoire with Epsteinbarr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto’s disease and systemic lupus erythematosus. J Immunol 141:4165–4172PubMed Nakamura M, Burastero SE, Ueki Y, Larrick JW, Notkins AL, Casali P (1988) Probing the normal and autoimmune B cell repertoire with Epsteinbarr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto’s disease and systemic lupus erythematosus. J Immunol 141:4165–4172PubMed
Metadaten
Titel
Lack of anti-insulin, anti-GAD, and anti-IA2 autoantibodies in primary antiphospholipid syndrome
verfasst von
Jozélio Freire de Carvalho
Maria Teresa Correia Caleiro
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 5/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1911-1

Weitere Artikel der Ausgabe 5/2012

Rheumatology International 5/2012 Zur Ausgabe

Letter to the Editor

Reply to Dua SG et al.

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.